Table 2 Plasma BMP-9 levels according to gender and various clinical phenotypes.
From: Circulating bone morphogenetic protein-9 in relation to metabolic syndrome and insulin resistance
Clinical phenotype | n | BMP-9 (ng/L) | P-value |
|---|---|---|---|
Female | 205 | 54.75(34.76,88.38) | Â |
Male | 157 | 51.38(31.20,97.13) | 0.789 |
Central obesity | 237 | 50.93(32.01,83.48) | Â |
Non-central obesity | 125 | 61.58(38.71,102.31) | <0.05 |
Dyslipidemia | 270 | 49.73(32.11,84.29) | Â |
Normal lipid | 92 | 75.72(45.93,109.00) | <0.001 |
IR | 143 | 49.17(32.27,82.57) | Â |
Non-IR | 174 | 68.48(43.94,114.51) | <0.001 |
Hypertension | 193 | 49.72(31.20,81.25) | Â |
Normal BP | 169 | 59.75(35.19,110.75) | <0.001 |
MetS | 215 | 44.31(29.77,66.39) | Â |
Non-MetS | 147 | 78.39(47.78,140.29) | <0.001 |
